drugset / Trial / NCT03246620

Oral Olanzapine Versus Haloperidol or Diazepam

NCT03246620 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether oral olanzapine is safer (fewer adverse events) and more effective (shorter time to sedation) than conventional haloperidol or diazepam when used in the management of acute agitation in the emergency.

Timeline

Start
2017-09-01
Primary completion
2018-06-01
Completion
2018-06-01

Outcome

Outcome not reported

Stopped (Enrollment): “The study was terminated prematurely due to difficulties in patient recruitment and associated potential for selection bias.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diazepam Small molecule 2 mg Oral
Comparator Haloperidol Other / unclassified 2 mg Oral
Subject Olanzapine Small molecule 5 mg Oral

Indications

No indication recorded.